DHA Grants Initial Approval to Yas Healthcare for Pioneering Project in Partnership with National Cancer Centre Singapore In a landmark development for regional oncology care, the Dubai Health Authority (DHA) has granted initial approval to Yas Healthcare — a subsidiary…
In a move aimed at reshoring pharmaceutical production, President Donald Trump has signed a new executive order to streamline the approval and construction of domestic drug manufacturing facilities. The order directs the FDA to eliminate “duplicative and unnecessary requirements,” reducing…
In a regional first, the Department of Health – Abu Dhabi (DoH), in collaboration with M42’s Biogenix Lab, has introduced APOE E4 genetic testing into its pharmacogenomics (PGx) reports, marking a significant advancement in the personalised care of Alzheimer’s disease.…
Abu Dhabi, UAE – In a strategic move to enhance the Emirate’s capabilities in clinical research and pharmaceutical innovation, the Department of Health – Abu Dhabi (DoH) and the Abu Dhabi Investment Office (ADIO) have signed a Memorandum of Understanding…
Hikma Pharmaceuticals PLC (Hikma), a leading multinational pharmaceutical group, has signed a strategic Memorandum of Understanding (MOU) with M42, a global health innovator powered by AI and technology, to drive advancements in colorectal cancer screening in the United Arab Emirates…
